BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16837548)

  • 1. Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction.
    Frantz S; Hu K; Bayer B; Gerondakis S; Strotmann J; Adamek A; Ertl G; Bauersachs J
    FASEB J; 2006 Sep; 20(11):1918-20. PubMed ID: 16837548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction.
    Kawano S; Kubota T; Monden Y; Tsutsumi T; Inoue T; Kawamura N; Tsutsui H; Sunagawa K
    Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1337-44. PubMed ID: 16632551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury.
    Frantz S; Tillmanns J; Kuhlencordt PJ; Schmidt I; Adamek A; Dienesch C; Thum T; Gerondakis S; Ertl G; Bauersachs J
    Am J Pathol; 2007 Aug; 171(2):507-12. PubMed ID: 17556593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
    Shishido T; Nozaki N; Yamaguchi S; Shibata Y; Nitobe J; Miyamoto T; Takahashi H; Arimoto T; Maeda K; Yamakawa M; Takeuchi O; Akira S; Takeishi Y; Kubota I
    Circulation; 2003 Dec; 108(23):2905-10. PubMed ID: 14656915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.
    Kawamura N; Kubota T; Kawano S; Monden Y; Feldman AM; Tsutsui H; Takeshita A; Sunagawa K
    Cardiovasc Res; 2005 Jun; 66(3):520-9. PubMed ID: 15914117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX.
    Frantz S; Brandes RP; Hu K; Rammelt K; Wolf J; Scheuermann H; Ertl G; Bauersachs J
    Basic Res Cardiol; 2006 Mar; 101(2):127-32. PubMed ID: 16273323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nuclear Factor-kappa B p50 subunit is involved in flow-induced outward arterial remodeling.
    van Keulen JK; Timmers L; van Kuijk LP; Retnam L; Hoefer IE; Pasterkamp G; Lim SK; de Kleijn DP
    Atherosclerosis; 2009 Feb; 202(2):424-30. PubMed ID: 18617174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction.
    Frantz S; Hu K; Widder J; Bayer B; Witzel CC; Schmidt I; Galuppo P; Strotmann J; Ertl G; Bauersachs J
    Br J Pharmacol; 2004 Jan; 141(1):9-14. PubMed ID: 14662734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II.
    Kawano S; Kubota T; Monden Y; Kawamura N; Tsutsui H; Takeshita A; Sunagawa K
    Cardiovasc Res; 2005 Sep; 67(4):689-98. PubMed ID: 15921667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
    Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
    Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
    J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction.
    Frantz S; Ducharme A; Sawyer D; Rohde LE; Kobzik L; Fukazawa R; Tracey D; Allen H; Lee RT; Kelly RA
    J Mol Cell Cardiol; 2003 Jun; 35(6):685-94. PubMed ID: 12788386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-κB signaling pathway.
    He Q; Zhou W; Xiong C; Tan G; Chen M
    Mol Med Rep; 2015 Jan; 11(1):374-8. PubMed ID: 25323011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Nrf2 promotes rapid progression to heart failure following myocardial infarction.
    Strom J; Chen QM
    Toxicol Appl Pharmacol; 2017 Jul; 327():52-58. PubMed ID: 28373008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCP-1-induced protein attenuates post-infarct cardiac remodeling and dysfunction through mitigating NF-κB activation and suppressing inflammation-associated microRNA expression.
    Niu J; Jin Z; Kim H; Kolattukudy PE
    Basic Res Cardiol; 2015 May; 110(3):26. PubMed ID: 25840774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases.
    Panzer U; Steinmetz OM; Turner JE; Meyer-Schwesinger C; von Ruffer C; Meyer TN; Zahner G; Gómez-Guerrero C; Schmid RM; Helmchen U; Moeckel GW; Wolf G; Stahl RA; Thaiss F
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F429-39. PubMed ID: 19458123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin protects against the development of systolic dysfunction following myocardial infarction.
    Shibata R; Izumiya Y; Sato K; Papanicolaou K; Kihara S; Colucci WS; Sam F; Ouchi N; Walsh K
    J Mol Cell Cardiol; 2007 Jun; 42(6):1065-74. PubMed ID: 17499764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.